Business and Finance

Deal expands GE’s $3 billion ultrasound business from diagnostics into surgical and therapeutic interventions

Firms will merge under the CSafe brand, allowing for delivery of temperature-sensitive items

ABC’s new acquisition, FirstView Financial, addresses underpayment of pharmacies, as well as patient assistance programs

Purchase of Engage grows the company’s knowledge in the data and analytics space

Deal expands pharma giant’s influence in inflammation and immunology markets

The $17.4-billion deal, CDMO says, will help expand its offerings in the clinical development space

Via investment partnership with Taishin Holdings, will begin offering manufacturing services in C&GT space

Upon deal completion, group will acquire company’s oncology product portfolio for $846 million

CDMO’s financial commitment will feature construction of a new GMP clinical trial development facility

Financial commitment is predicted to more than double the biopharma site’s manufacturing capabilities

Transaction expands CDMO’s services, including more solutions surrounding commercial manufacturing

Five-year deal covers manufacturing of molecules, ranging from monoclonal antibodies to antibody-drug conjugates

Subject to regulatory approval, CDMO will produce mRNA vaccine on a commercial scale

The Discovery Centre will be powered by AI technology, robotics, among other features

Transaction is anticipated to further Novo’s research in the field of RNAi therapeutics

Acquisition of biopharma company features sotatercept, which is in Phase III trials for the treatment of pulmonary arterial hypertension

Financial commitment expected to increase plant's process development and manufacturing capacity

Industrialized collaboration is critical to taking next-generation cell and gene therapies to the next level—if companies can build on pandemic-partnering momentum

Separation process expected to be completed in 18-24 months

Expansion expected to more than double the plant’s footprint

CDMO’s expansion of Hopkinton, MA facility will include seven new ISO 7 cGMP suites

Deal expected to boost firm’s offerings via FDS's delivery system services

Partnership further increases investment firm’s repertoire in healthcare space

Boston area facility will focus heavily on cold chain services

Parties expect improved design and selection of eCOAs in decentralized clinical trials